The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over ...

WARSAW, Ind., May 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it will host an Investor Day on Wednesday, May 29, 2024, at 1:00 p.m. E.T. until approximately 4:30 p.m. ET at the New York Stock Exchange in New York City. The event will feature presentations by members of the senior management team, including President and CEO Ivan Tornos and Chief Financial Officer, EVP, Finance, Operations and Supply Chain Suky Upadhyay, ...

Zimmer Biomet (ZBH) is well-poised to grow in the coming quarters owing to the encouraging business recovery and increased provider capacity driving backlog pull-through. The company also progresses on the four-pillar strategy to expand the Knee business. Further, the global musculoskeletal market's gradual stabilization bodes well for its operations. Meanwhile, unfavorable solvency and currency fluctuations raise concerns for Zimmer Biomet. In the past year, this Zacks Rank #3 (Hold) stock has declined 11% ...

WARSAW, Ind., May 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2024. The cash dividend of $0.24 per share is payable on or about July 31, 2024 to stockholders of record as of the close of business on June 26, 2024. About Zimmer Biomet Zimmer Biomet is a global medical technology leader with a comprehensi ...

As detailed in the report, Zimmer Biomet is committed to being a good corporate citizen and a leader in responsible, ethical business practices. Key highlights include: Achieving the highest ever employee engagement levels since our 2015 merger. Our company-wide engagement index score increased a remarkable 7 points over 2022 results, with improved scores for 100% of the indicators. Furthering our commitment to integrating health equity into our business strategy. Our new Community Centered Care (C3) frame ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2024 Commission File Number 001-16407 ZIMMER BIOMET HOLDINGS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 13-4151777 (IRS Employer Identification No.) 345 East Main Street, Warsaw, IN 46580 (Address of principal e ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Keri Mattox - Chief Communications and Administration Officer Ivan Tornos - President and CEO Suky Upadhyay - Executive Vice President, Finance, Operations and Supply Chain, and CFO Conference Call Participants Travis Steed - Bank of America Steve Lichtman - Oppenheimer & Company Vik Chopra - Wells Fargo Rick Wise - Stifel Imron Zafar - Deutsche Bank Caitlin Cronin - Canaccord Genuity Mike Ma ...

Zimmer Biomet Holdings, Inc. (ZBH) posted first-quarter 2024 adjusted earnings per share (EPS) of $1.94, exceeding the Zacks Consensus Estimate by 3.7%. The adjusted figure increased 2.6% year over year.The quarter’s adjustments included certain amortization, restructuring and other cost reduction initiatives and European Union Medical Device Regulation-related charges, among others.On a reported basis, the company registered earnings of 84 cents per share, which reflected a 24.3% decline from the year-ago ...

For the quarter ended March 2024, Zimmer Biomet (ZBH) reported revenue of $1.89 billion, up 3.2% over the same period last year. EPS came in at $1.94, compared to $1.89 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.87 billion, representing a surprise of +1.16%. The company delivered an EPS surprise of +3.74%, with the consensus EPS estimate being $1.87.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ex ...

Zimmer Biomet (ZBH) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.87 per share. This compares to earnings of $1.89 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.74%. A quarter ago, it was expected that this orthopedic device maker would post earnings of $2.15 per share when it actually produced earnings of $2.20, delivering a surprise of 2.33%.Over the last four quarters, t ...